Otc

Otc articles

Chloroflouorocarbons OTC asthma inhalers will no longer be made or sold in US
The U.S. Food and Drug Administration says users of epinephrine inhalers containing chlorofluorocarbons (CFCs) should plan now to get a prescription for a replacement product because these inhalers will not be made or sold after Dec_31, 2011.

Widespread use of medications among pregnant women
There is widespread and increasing medication use among pregnant women, revealed by researchers from Boston University's Slone Epidemiology Center, in collaboration with the Centers for Disease Control and Prevention (CDC) and Harvard School of Public Health,

US company starts clinical trial using stem cells to treat macular degeneration
Advanced Cell Technology, Inc. ("ACT"; OTCBB:ACTC) announced that the US Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application to immediately initiate a Phase I/II multicenter clinical trial using retinal cells derived from human embryonic stem cells (hESCs) to treat patients with Stargardt's Macular Dystrophy (SMD), one of the most common forms of juvenile macular degeneration in the world.

Use broad spectrum sunscreen to protect against UV rays
Sunscreen active ingredients, which are compounds that absorb, scatter or reflect ultraviolet (UV) light, are regulated as over-the-counter (OTC) drugs by the U.S. Food and Drug Administration (FDA).

Actemra, tocilizumab approved for Rheumatoid Arthritis
Genentech, Inc. , a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) approved ACTEMRA® (tocilizumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies.

Prevacid clinically proven to treat frequent heartburn
Novartis announced the availability of Prevacid 24HR (lansoprazole delayed-release capsules 15 mg/acid reducer) over-the-counter in pharmacies and retail stores across the US to treat frequent heartburn.

Certain Zicam cold remedies linked to loss of sense of smell
The U.S. Food and Drug Administration advised consumers to stop using three products marketed over-the-counter (OTC) as cold remedies because they are associated with the loss of sense of smell (anosmia).

1 in 4 surgeons fixing botched permanent filler ops
With recent reports of women suffering complications due to cosmetic fillers, the British Association of Aesthetic Plastic Surgeons unveil survey results detailing their top concerns regarding these popular non-surgical treatments.

Eye wrinkles removal laser device gets OTC
US health agency FDA (Food and Drug Administration) approved over-the-counter (OTC) marketing of Palomar's laser device for treatment of wrinkles around the eyes, i.e. periorbital wrinkles.

Plan B as OTC for 17 year old women
The Food and Drug Administration (FDA) announced that it will not appeal a U.S. District Court order that 17 year old girls should have unrestricted, over-the-counter access to Plan B or so-called "emergency contraception."

GSK launches OTC weight loss drug alli, orlistat in Europe
GlaxoSmithKline (GSK) has announced that alli – the first clinically proven over the counter weight loss aid – is available in pharmacies across Europe.

Parents still using pediatric OTC cough and cold medications
A new survey conducted in March 2009 by Harris Interactive® and commissioned by Bionorica shows that while 90% of parents claim to be at least somewhat knowledgeable about the level of effectiveness and the possible dangers associated with over-the-counter (OTC) cough and cold products for children, 62% still give these products to children when they are experiencing cough and cold symptoms.

Advice for treatment of cough, colds in children under 6
Responding to guidance issued by the Medicines and Healthcare products Regulatory Agency (MHRA), advising that cough and cold treatments should not be used for children under 6 years of age, the Royal Pharmaceutical Society of Great Britain (RPSGB) has issued the following advice to parents.

Live cell therapy clinical trial in New Zealand for diabetics
Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) announced that New Zealand Health Minister, the Honorable David Cunliffe, has approved an application from the company to conduct in New Zealand a Phase I/IIa clinical trial of DiabeCell®, LCT's lead product candidate for the treatment of insulin dependent (Type 1) diabetes.

Label updates of oral OTC children's cough and cold medicines
The following statement was issued by Linda Suydam, president of Consumer Healthcare Products Association, USA, on the Voluntary Label Updates to Oral OTC Children's Cough and Cold Medicines.

Breast stem cell fate is regulated by notch
A normal developmental protein that sometimes goes awry has been implicated in breast cancer. This discovery indicates the mechanism by which inappropriate expression of the Notch pathway may contribute to breast cancer.

OTC eardrops may cause hearing loss
A new study, led by researchers at The Montreal Children's Hospital (MCH) of the MUHC, has revealed that certain over-the-counter earwax softeners can cause severe inflammation and damage to the eardrum and inner ear. The results of the study, recently published in The Laryngoscope, suggest that use of these medications should be discouraged.

Consumer Healthcare supports FDA over OTC cough and cold medicines withdrawal
On behalf of the leading makers of over-the-counter (OTC) cough and cold medicines, the Consumer Healthcare Products Association (CHPA) offered its support for U.S. Food and Drug Administration (FDA) decision against the use of oral OTC cough and cold medicines in children under the age of two.

Use OTC cough and cold products with care
US health agency FDA is recommending that over-the-counter (OTC) cough and cold products should not be used to treat infants and children less than 2 years of age because serious and potentially life-threatening side effects can occur from such use. OTC cough and cold products include decongestants, expectorants, antihistamines, and antitussives (cough suppressants) for the treatment of colds.

New warning for nonoxynol 9 OTC contraceptives in US
The U.S. Food and Drug Administration (FDA) issued a final rule that requires that manufacturers of over-the-counter (OTC) stand-alone vaginal contraceptive and spermicidal products containing the chemical ingredient nonoxynol 9 (N9) include a warning that the chemical N9 does not provide protection against infection from HIV (the virus that causes AIDS) or other sexually transmitted diseases (STDs).

20 Otc articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.8